Icon

SANCUSO (nda022198)- (3.1MG/24HR)

GRANISETRON CUMBERLAND
3.1MG/24HR
Yes Yes
2025-Jan-22 Expired
None None
None No
Sancuso is a serotonin-3 (5-HT3) receptor antagonist indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days.
0 0 0
Total Other Developers None
Drugs with Suitability No
3.1MG/24HR ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.